Meta‑analysis of the diagnostic value of serum, plasma and urine neutrophil gelatinase‑associated lipocalin for the detection of acute kidney injury in patients with sepsis

Zhou,Hong; Cui,Juan; Lu,You; Sun,Jing; Liu,Jianzhou

doi:10.3892/etm.2021.9817

Meta‑analysis of the diagnostic value of serum, plasma and urine neutrophil gelatinase‑associated lipocalin for the detection of acute kidney injury in patients with sepsis

Authors:
- Hong Zhou
- Juan Cui
- You Lu
- Jing Sun
- Jianzhou Liu
View Affiliations

Affiliations: Department of Emergency, Emergency General Hospital, Chaoyang, Beijing 100028, P.R. China, Department of Pharmacy, Emergency General Hospital, Chaoyang, Beijing 100028, P.R. China, Department of Cardiac Surgery, Peking Union Medical College Hospital, Beijing 100730, P.R. China
Published online on: February 23, 2021 https://doi.org/10.3892/etm.2021.9817
Article Number: 386
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The objective of the present study was to assess the diagnostic value of urine, serum and plasma neutrophil gelatinase‑associated lipocalin (NGAL) for the early diagnosis of acute kidney injury (AKI) among patients with suspected sepsis. Therefore, a meta‑analysis was carried out to evaluate diagnostic accuracy data from the literature regarding the diagnosis of AKI in patients with sepsis. Electronic databases were systematically searched for relevant studies and quality assessment was conducted using the Quality Assessment for Diagnostic Accuracy Studies 2 tool. A summary receiver operating characteristic curve analysis was performed, and several parameters including sensitivity, specificity, diagnosis odds ratio (DOR) and area under the curve (AUC) were calculated to evaluate the diagnostic performance of urine, serum and plasma NGAL. Meta‑regression, sensitivity and subgroup analysis were also conducted to identify the source of heterogeneity in the eligible studies. In total, 28 studies were included. The pooled sensitivities for urine, serum and plasma NGAL were 0.87, 0.83 and 0.80, respectively. Pooled specificity was 0.84, 0.79 and 0.74. The DORs were 35, 18 and 11, respectively. The AUC for urine, serum and plasma NGAL were 0.92, 0.87 and 0.84, respectively. Urine NGAL presented superior performance for the diagnosis of AKI with the highest AUC and other diagnostic accuracy values, compared with serum and plasma NGAL. Further studies are needed to clarify the controversial issue between the usefulness of serum and plasma NGAL.

View Figures

View References

1	Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W and Vanholder R: Acute kidney injury: An increasing global concern. Lancet. 382:170–179. 2013.PubMed/NCBI View Article : Google Scholar
2	Kellum JA, Wen X, de Caestecker MP and Hukriede NA: Sepsis-associated acute kidney injury: A problem deserving of new solutions. Nephron. 143:174–178. 2019.PubMed/NCBI View Article : Google Scholar
3	Zarbock A, Gomez H and Kellum JA: Sepsis-induced acute kidney injury revisited: Pathophysiology, prevention and future therapies. Curr Opin Crit Care. 20:588–595. 2014.PubMed/NCBI View Article : Google Scholar
4	Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, Bagshaw SM, Glassford NJ, Lankadeva Y, Vaara ST and Schneider A: Acute kidney injury in sepsis. Intensive Care Med. 43:816–828. 2017.PubMed/NCBI View Article : Google Scholar
5	JX W, HS Z and XL C: Clinical significance of renal biomarkers for early evaluation of acute kidney injury in sepsis. Chin J Crit Care Intensive Care Med. 5:132–138. 2019.
6	Zhang A, Cai Y, Wang PF, Qu JN, Luo ZC, Chen XD, Huang B, Liu Y, Huang WQ, Wu J and Yin YH: Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: A systematic review and meta-analysis. Crit Care. 20:41. 2016.PubMed/NCBI View Article : Google Scholar
7	Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J and Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 14:2534–2543. 2003.PubMed/NCBI View Article : Google Scholar
8	Chakraborty S, Kaur S, Guha S and Batra SK: The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta. 1826:129–169. 2012.PubMed/NCBI View Article : Google Scholar
9	Haase M, Bellomo R, Devarajan P, Schlattmann P and Haase-Fielitz A: NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis. 54:1012–1024. 2009.PubMed/NCBI View Article : Google Scholar
10	Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM and Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest. 101:1644–1655. 1992.PubMed/NCBI View Article : Google Scholar
11	Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL and Ramsay G: SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 31:1250–1256. 2003.PubMed/NCBI View Article : Google Scholar
12	Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 39:165–228. 2013.PubMed/NCBI View Article : Google Scholar
13	Khawaja S, Jafri L, Siddiqui I, Hashmi M and Ghani F: The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients. Biomark Res. 7(4)2019.PubMed/NCBI View Article : Google Scholar
14	Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG and Levin A: Acute Kidney Injury Network. Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 11(R31)2007.PubMed/NCBI View Article : Google Scholar
15	Kellum JA and Lameire N: KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1). Crit Care. 17(204)2013.PubMed/NCBI View Article : Google Scholar
16	Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA and Bossuyt PM: QUADAS-2 Group. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 155:529–536. 2011.PubMed/NCBI View Article : Google Scholar
17	Higgins JP and Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1, 2009.
18	Arends LR, Hamza TH, van Houwelingen JC, Heijenbrok-Kal MH, Hunink MG and Stijnen T: Bivariate random effects meta-analysis of ROC curves. Med Decis Making. 28:621–638. 2008.PubMed/NCBI View Article : Google Scholar
19	Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH, et al: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 343(d4002)2011.PubMed/NCBI View Article : Google Scholar
20	Yang YB, Li YH, Chen XQ, Lv LH and Mei WL: Diagnostic value of serum NGAL and CysC levels in sepsis patients with acute kidney injury. Zhejiang Med J. 41:1025–1029. 2019.
21	RQ L, ZY M, HG C and ZC L: Diagnostic efficacy of serum NGAL, KIM-1 and Cys-C for acute kidney injury in sepsis patients. China Med Herald. 16:128–131. 2019.
22	da Rocha EP, Yokota LG, Sampaio BM, Cardoso Eid KZ, Dias DB, de Freitas FM, Balbi AL and Ponce D: Urinary neutrophil gelatinase-associated lipocalin is excellent predictor of acute kidney injury in septic elderly patients. Aging Dis. 9:182–191. 2018.PubMed/NCBI View Article : Google Scholar
23	Zheng J, He HL and Zhang GY: Neutrophil gelatinase-associated lipocalin as diagnosis biomarker for acute renal injury in pediatric patients with sepsis in intensive care unit. J Third Mil Med Univ. 39:196–200. 2017.
24	Shang Y, Li J, Zhang J, Wang W, Qiao Y and Ren X: Predictive performance of neutrophil gelatinase-associated lipocalin (NGAL) in acute kidney injury in septic patients. Chin J Emerg Med. 26:538–543. 2017.
25	Md Ralib A, Mat Nor MB and Pickering JW: Plasma neutrophil gelatinase-associated lipocalin diagnosed acute kidney injury in patients with systemic inflammatory disease and sepsis. Nephrology (Carlton). 22:412–419. 2017.PubMed/NCBI View Article : Google Scholar
26	Patel ML, Sachan R, Shyam R, Kumar S, Kamal R and Misra A: Diagnostic accuracy of urinary neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury. Int J Nephrol Renovasc Dis. 9:161–169. 2016.PubMed/NCBI View Article : Google Scholar
27	Huang CY, Shih CC, Chung K, Kao KC and Wu HP: Predictive value of plasma neutrophil gelatinase-associated lipocalin for acute renal failure in patients with severe sepsis. J Chin Med Assoc. 79:428–434. 2016.PubMed/NCBI View Article : Google Scholar
28	Zhang JG, Zhang DH, Zhu HP and Liu S: The clinical value of NGAL in the early diagnosis of sepsis-induced kidney injury. China Pract Med. 10:46–47. 2015.
29	Niu KY, Yang F, Yang XY, Ye J and Cheng JJ: Diagnostic value of urinary liver-type fatty acid binding proteins and urinary neutrophil gelatinase-associated lipocalin in severe sepsis patients with acute kidney injury. Clin Focus. 5:536–539. 2015.
30	Nga HS, Medeiros P, Menezes P, Bridi R, Balbi A and Ponce D: Sepsis and AKI in clinical emergency room patients: The role of urinary NGAL. Biomed Res Int. 2015(413751)2015.PubMed/NCBI View Article : Google Scholar
31	Meng DL, Xing HB, Mao RS, et al: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury patients with sepsis. Zhongguo Jijiu Yixue. 224–229. 2015.
32	Hjortrup PB, Haase N, Treschow F, Moller MH and Perner A: Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis. Acta Anaesthesiol Scand. 59:25–34. 2015.PubMed/NCBI View Article : Google Scholar
33	Zhou HQ, Chen MQ, Zhang HD and Wang X: sTREM-1 and NGAL levels for the early diagnosis of sepsis complicated by acute kidney injury. J Clin Exp Med. 21:1773–1775. 2014.
34	Wang XH and Zhang T: The value of NGAL in early diagnosis of acute kidney injury in children with sepsis. Pract Prev Med. 21:745–747. 2014.
35	Wang HX, Mu HB, Zheng RQ, Lin H, Yu JQ and Wu XY: Early diagnosis of neutrophil gelatinase-associated apolipoprotein in patients with acute kidney injury in sepsis. Shiyong Linchuang Yiyao Zazhi. 18:183–184. 2014.
36	Fan H, Zhao Y, Zhu JH and Song FC: Urine neutrophil gelatinase-associated lipocalin in septic patients with and without acute kidney injury. Ren Fail. 36:1399–1403. 2014.PubMed/NCBI View Article : Google Scholar
37	Xing HB, Lv T, Sheng PP, Chen JD, Mao RS and Li D: The diagnostic value of new biomarkers in sepsis patients with acute kidney injury. Zhongguo Jijiu Yixue. 33:507–510. 2013.
38	de Geus HR, Betjes MG, Schaick RV and Groeneveld JA: Plasma NGAL similarly predicts acute kidney injury in sepsis and nonsepsis. Biomark Med. 7:415–421. 2013.PubMed/NCBI View Article : Google Scholar
39	Camou F, Oger S, Paroissin C, Guilhon E, Guisset O, Mourissoux G, Pouyes H, Lalanne T and Gabinski C: Plasma neutrophil gelatinase-associated lipocalin (NGAL) predicts acute kidney injury in septic shock at ICU admission. Ann Fr Anesth Reanim. 32:157–164. 2013.PubMed/NCBI View Article : Google Scholar : (In French).
40	Aydoğdu M, Gürsel G, Sancak B, Yeni S, Sarı G, Taşyürek S, Türk M, Yüksel S, Senes M and Ozis TN: The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients. Dis Markers. 34:237–246. 2013.PubMed/NCBI View Article : Google Scholar
41	El-Farghali OG, El-Raggal NM, Mahmoud NH and Zaina GA: Serum neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in critically-ill neonates. Pak J Biol Sci. 15:231–237. 2012.PubMed/NCBI View Article : Google Scholar
42	Yan J, Xu HY, Zang D, Liang FM and Yang T: Significance of early diagnosis of urinary neutrophil gelatinase-associated lipocalin and urinary interleukin-18 in patients with sepsis complicated with acute kidney injury. Suzhou Univ J Med Sci. 31:785–788. 2011.
43	Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson K, Milzman D, et al: The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med. 56:52–59.e1. 2010.PubMed/NCBI View Article : Google Scholar
44	Mårtensson J, Bell M, Oldner A, Xu S, Venge P and Martling CR: Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med. 36:1333–1340. 2010.PubMed/NCBI View Article : Google Scholar
45	Li PZ and Xu WX: Prediction of acute kidney injury complicated by sepsis with neutronphil gelatinase-associated lipocalin as an early marker. Chin J Lab Med. 33:492–496. 2010.
46	Shapiro DE: The interpretation of diagnostic tests. Stat Methods Med Res. 8:113–134. 1999.PubMed/NCBI View Article : Google Scholar
47	Törnblom S, Nisulal S, Petäjä L, Vaara ST, Haapio M, Pesonen E and Pettilä V: FINNAKI study group. Urine NGAL as a biomarker for septic AKI: A critical appraisal of clinical utility-data from the observational FINNAKI study. Ann Intensive Care. 10(51)2020.PubMed/NCBI View Article : Google Scholar
48	Seliger SL, Davis C and Stehman-Breen C: Gender and the progression of renal disease. Curr Opin Nephrol Hypertens. 10:219–225. 2001.PubMed/NCBI View Article : Google Scholar
49	Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, et al: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 115:610–621. 2005.PubMed/NCBI View Article : Google Scholar
50	de Geus HR, Woo JG, Wang Y, Devarajan P, Betjes MG, le Noble JL and Bakker J: Urinary neutrophil gelatinase-associated lipocalin measured on admission to the intensive care unit accurately discriminates between sustained and transient acute kidney injury in adult critically ill patients. Nephron Extra. 1:9–23. 2011.PubMed/NCBI View Article : Google Scholar